The prolongation effect of ilaprazole-based standard triple therapy for Helicobacter pylori.

ABSTRACT:

Background

Helicobacter pylori (HP) infection causes many diseases, such as peptic ulcers, gastritis and gastric cancer, and MALToma. It has been gradually accepted that all HP-infected patients should be treated because HP is regarded as an infection. Therefore, the importance of selecting the optimal treatment regimen has increased. Although the 14-day standard triple therapy (STT) is recommended in the current guidelines, prolonging treatment duration is controversial in real practice because of inconsistent results from previous data and the risk of adverse effects. Additionally, the effect of STT using ilaprazole has not been reported until now. We aimed to compare the eradication rate between 7 and 10 days STT using ilaprazole.

Methods

A prospective randomized controll

SUBMITTER: Lee SW 

PROVIDER: S-EPMC7505311 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature